2321.Hk
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.
The company maintains a market price of MYR 0.48, with a market capitalization of MYR 480.08 million, and a price-to-earnings ratio of 14.44, indicating a moderate valuation relative to earnings. The price-to-book ratio of 1.75 suggests that the company's market value is 75% higher than its book value, reflecting investor confidence in its intangible assets and future earnings potential. The company's liquidity position is characterized by a current ratio of 2.91, which is above the industry median, indicating a strong ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, the company reports a return on equity (ROE) of 12.14% and a return on assets (ROA) of 7.43%, both of which are above the industry median, suggesting efficient use of equity and assets to generate profit. The operating margin, calculated as operating income of MYR 44.21 million on revenue of MYR 932.89 million, is 4.74%, which is in line with the industry average. The company's gross profit margin of 13.07% is also consistent with the industry median, indicating that it is effectively managing its cost of goods sold.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which may expose it to regional economic fluctuations. The company's debt-to-equity ratio of 0.33 is below the industry median, indicating a conservative capital structure with limited leverage. The company's total liabilities of MYR 173.55 million are significantly lower than its total equity of MYR 273.68 million, further supporting its financial stability.
Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The company's long-term debt of MYR 89.74 million is manageable given its equity base, but any increase in debt could affect its credit profile. The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's financial structure is supported by a strong equity base, but its negative net cash position may require monitoring.
Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's financial performance and risk profile remain stable, with no immediate concerns for investors.
- The company has a moderate valuation with a price-to-earnings ratio of 14.44 and a price-to-book ratio of 1.75.
- The company's profitability metrics, including ROE of 12.14% and ROA of 7.43%, are above the industry median.
- The company's capital structure is conservative, with a debt-to-equity ratio of 0.33 and a current ratio of 2.91.
- The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
- The company's liquidity position is medium risk, with a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 2321.HK Market data — financials · 2026-05-26